Lindsay B. Avery, Ph.D. - Publications

Affiliations: 
2012 Johns Hopkins University, Baltimore, MD 
Area:
Pharmacology, General Biophysics, Pharmaceutical Chemistry

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Surcel A, Ng WP, West-Foyle H, Zhu Q, Ren Y, Avery LB, Krenc AK, Meyers DJ, Rock RS, Anders RA, Freel Meyers CL, Robinson DN. Pharmacological activation of myosin II paralogs to correct cell mechanics defects. Proceedings of the National Academy of Sciences of the United States of America. 112: 1428-33. PMID 25605895 DOI: 10.1073/pnas.1412592112  0.6
2014 Prusevich P, Kalin JH, Ming SA, Basso M, Givens J, Li X, Hu J, Taylor MS, Cieniewicz AM, Hsiao PY, Huang R, Roberson H, Adejola N, Avery LB, Casero RA, et al. A selective phenelzine analogue inhibitor of histone demethylase LSD1. Acs Chemical Biology. 9: 1284-93. PMID 24707965 DOI: 10.1021/cb500018s  0.6
2014 Avery LB, Bumpus NN. Valproic acid is a novel activator of AMP-activated protein kinase and decreases liver mass, hepatic fat accumulation, and serum glucose in obese mice. Molecular Pharmacology. 85: 1-10. PMID 24105977 DOI: 10.1124/mol.113.089755  0.6
2013 Kelly KM, Beck SE, Metcalf Pate KA, Queen SE, Dorsey JL, Adams RJ, Avery LB, Hubbard W, Tarwater PM, Mankowski JL. Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: reduced replicating and latent SIV in the brain. Aids (London, England). 27: F21-8. PMID 24051706 DOI: 10.1097/QAD.0000000000000074  0.6
2013 Lade JM, Avery LB, Bumpus NN. Human biotransformation of the nonnucleoside reverse transcriptase inhibitor rilpivirine and a cross-species metabolism comparison. Antimicrobial Agents and Chemotherapy. 57: 5067-79. PMID 23917319 DOI: 10.1128/AAC.01401-13  0.6
2013 Avery LB, Zarr MA, Bakshi RP, Siliciano RF, Hendrix CW. Increasing extracellular protein concentration reduces intracellular antiretroviral drug concentration and antiviral effect. Aids Research and Human Retroviruses. 29: 1434-42. PMID 23601085 DOI: 10.1089/AID.2013.0031  0.6
2013 Avery LB, Sacktor N, McArthur JC, Hendrix CW. Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration. Antimicrobial Agents and Chemotherapy. 57: 1409-14. PMID 23295919 DOI: 10.1128/AAC.02329-12  0.6
2013 Avery LB, VanAusdall JL, Hendrix CW, Bumpus NN. Compartmentalization and antiviral effect of efavirenz metabolites in blood plasma, seminal plasma, and cerebrospinal fluid. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 422-9. PMID 23166317 DOI: 10.1124/dmd.112.049601  0.6
2012 Tovar-y-Romo LB, Bumpus NN, Pomerantz D, Avery LB, Sacktor N, McArthur JC, Haughey NJ. Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz. The Journal of Pharmacology and Experimental Therapeutics. 343: 696-703. PMID 22984227 DOI: 10.1124/jpet.112.195701  0.6
2011 Avery LB, Bakshi RP, Cao YJ, Hendrix CW. The male genital tract is not a pharmacological sanctuary from efavirenz. Clinical Pharmacology and Therapeutics. 90: 151-6. PMID 21633344 DOI: 10.1038/clpt.2011.99  0.6
2010 Avery LB, Parsons TL, Meyers DJ, Hubbard WC. A highly sensitive ultra performance liquid chromatography-tandem mass spectrometric (UPLC-MS/MS) technique for quantitation of protein free and bound efavirenz (EFV) in human seminal and blood plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 878: 3217-24. PMID 21036679 DOI: 10.1016/j.jchromb.2010.09.011  0.6
Show low-probability matches.